Microbiota modulation for infectious complications following allogeneic hematopoietic stem cell transplantation in
Wei Dai1, Xiaofan Chen1, Huanhuan Zhou1
1Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China.
Abstract:
The intervention of microbiota modulation in the treatment of infection complications after allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies has shown potential benefits. Through the use of probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT), these interventions modulate the gut microbiota and enhance immune function to prevent and treat infections. They have been shown to reduce the incidence of diarrhea and intestinal infections, mitigate the issue of antibiotic resistance, and promote the recovery of gut microbiota. Future research is needed to further assess the safety and efficacy of these interventions and to establish standardized treatment protocols.
Insights
Microbiota modulation using probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT) shows promise in treating infections after stem cell transplants in pediatric cancer patients. These therapies improve gut health, reduce infections, and combat antibiotic resistance.
Area of Science:
- Pediatric Hematology Oncology
- Microbiome Research
- Infectious Diseases
Background:
- Allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with hematological malignancies is associated with significant infection risks.
- Gut microbiota dysbiosis is a major contributor to infection complications and treatment challenges post-HSCT.
- Current treatment strategies have limitations in preventing and managing these infections effectively.
Purpose of the Study:
- To evaluate the potential benefits of microbiota modulation interventions in pediatric patients undergoing HSCT.
- To explore the role of probiotics, prebiotics, synbiotics, and fecal microbiota transplantation (FMT) in managing infection complications.
- To assess the impact of these interventions on immune function, gut microbiota recovery, and antibiotic resistance.
Main Methods:
- Review of studies investigating microbiota modulation therapies (probiotics, prebiotics, synbiotics, FMT) in pediatric HSCT recipients.
- Analysis of outcomes related to infection incidence, severity, and treatment.
- Assessment of changes in gut microbiota composition and immune markers.
Main Results:
- Microbiota modulation interventions demonstrated potential in preventing and treating infections post-HSCT.
- These therapies were associated with a reduced incidence of diarrhea and intestinal infections.
- Positive effects on the recovery of gut microbiota and mitigation of antibiotic resistance were observed.
Conclusions:
- Microbiota modulation represents a promising therapeutic approach for infection complications following HSCT in pediatric hematological malignancy patients.
- Further research is warranted to establish safety, efficacy, and standardized protocols for these interventions.
- Optimizing gut microbiota may enhance immune reconstitution and improve outcomes in this vulnerable population.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:01Regulation of Hematopoietic Stem Cells
01:40Cell-mediated Immune Responses
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...